- Home
- TLSA
as 11-15-2024 4:00pm EST
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
| Founded: | 2013 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 87.8M | IPO Year: | 2000 |
| Target Price: | N/A | AVG Volume (30 days): | 384.8K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.13 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.41 - $1.74 | Next Earning Date: | 12-27-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Tiziana Life Sciences Ltd. News
TLSA Breaking Stock News: Dive into TLSA Ticker-Specific Updates for Smart Investing
GlobeNewswire
16 days ago
Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
GlobeNewswire
18 days ago
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
GlobeNewswire
19 days ago
Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
Simply Wall St.
21 days ago
Discover October 2024's Promising US Penny Stocks
TipRanks
22 days ago
Tiziana Life Sciences Plans Share Sale with Jefferies
TipRanks
a month ago
Tiziana Life Sciences Advances with Promising Drug Trials
GlobeNewswire
2 months ago
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
MT Newswires
3 months ago
Tiziana Life Sciences Names Ivor Elrifi as CEO
Compare TLSA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TLSA Tiziana Life Sciences Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.